Your browser doesn't support javascript.
loading
AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity.
Bloedjes, Timon A; de Wilde, Guus; Khan, Gerarda H; Ashby, Timothy C; Shaughnessy, John D; Zhan, Fenghuang; Houtkooper, Riekelt H; Bende, Richard J; van Noesel, Carel J M; Spaargaren, Marcel; Guikema, Jeroen E J.
Afiliación
  • Bloedjes TA; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • de Wilde G; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • Khan GH; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • Ashby TC; Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Shaughnessy JD; Department of Internal Medicine, Myeloma Center, Winthrop P. Rockefeller Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Zhan F; Department of Internal Medicine, Myeloma Center, Winthrop P. Rockefeller Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Houtkooper RH; Laboratory of Genetic Metabolic Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam, The Netherlands.
  • Bende RJ; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • van Noesel CJM; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • Spaargaren M; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • Guikema JEJ; Department of Pathology, Amsterdam University Medical Centers, University of Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
Blood Adv ; 7(9): 1697-1712, 2023 05 09.
Article en En | MEDLINE | ID: mdl-36322819
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-akt / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-akt / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos